VoiceLove app to improve communication, family engagement, and delirium in critically ill adults
Official title: VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)
Run by Vanderbilt University Medical Center · NCT06923462 · Data updated 2026-11-12
This trial will test whether the VoiceLove phone app helps families communicate with intubated adults in the medical or coronary ICU and whether it improves family engagement and reduces ICU delirium.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Status | Recruiting |
| Started | August 6, 2025 |
| Main results expected | March 15, 2027 |
| Study ends | March 15, 2028 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT06923462 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) admitted to the medical or coronary ICU at Vanderbilt who are intubated with expected mechanical ventilation >24 hours and who can consent or have an available surrogate, and who understand English.
✕Probably not a fit
Patients with acute or chronic neurologic deficits preventing delirium assessment, non–English speakers, prisoners, those expected to die or receive comfort-only measures, or those without available consent/surrogates are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
VoiceLove is a HIPAA-compliant mobile app that lets family members record, archive, and send real-time voice messages to patients who are intubated or otherwise unable to communicate. The study is a prospective, mixed-methods randomized controlled trial comparing VoiceLove implementation to usual care in the medical and coronary ICU. Outcomes include measures of patient-family communication, family engagement and satisfaction, feasibility and acceptability of the app, and prevalence of ICU delirium. Participants are adult ICU patients intubated with an expected duration >24 hours, with consent obtained from the patient or a surrogate.
Why it matters
Potential benefit: If successful, the app could increase family engagement and satisfaction, help maintain meaningful contact for nonverbal patients, and potentially reduce the frequency or severity of ICU delirium.
How similar studies have gone: Previous family-engagement and reorientation interventions have shown modest benefits for delirium and satisfaction, but app-based voice-message tools like VoiceLove remain largely untested in randomized trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Only patients who meet inclusion criteria, have no exclusion criteria, and consent for participation will advance to the Interventional Trial phase (i.e., the randomization phase) of the study. Patients will be eligible for inclusion in the Pre-Randomization Phase of the study (i.e., presented for study consent) if they are: 1. Adult patient ≥18 years old 2. Admitted to medical or coronary ICU 3. Intubated on mechanical ventilation with expected intubation of \> 24 hours Exclusion Criteria Patients will be excluded (i.e., not consented) for any of the following reasons: 1. Inability to obtain informed consent * Attending physician refusal * Patient and/or surrogate refusal * Patient unable to consent and no surrogate available 2. Acute or chronic neurologic deficit precluding CAM-ICU assessments 3. Inability to understand English 4. Current enrollment in a study that does not allow co-enrollment 5. Prisoners 6. Expected death or comfort measures within 24 hours of enrollment or lack of commitment to intervention by family or the medical team (e.g., likely to withdraw life support measures within 24 hours of enrollment). 7. Bilateral Deafness
Where it's running
-
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Principal investigator: E Wesley Ely, MD, MPH — Vanderbilt University Medical Center
- Study coordinator: Christina Boncyk, MD, MPH
- Email: christina.s.boncyk@vumc.org
- Phone: 615-936-2857
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RECOMMEND platform testing interventions for adults receiving ECMO
This platform tests whether different treatments, such as liberal versus restrictive red blood cell transfusion strategies, help adults on ECMO survive and need less organ support and hospital resources by day 28.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.